Olmesartan/Amlodipin/Hct Ratiopharm (Olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan/Amlodipin/Hct Ratiopharm, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension, often in combination with other antihypertensive agents, and is suitable for adult patients. GNH USA supplies Olmesartan/Amlodipin/Hct Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan/Amlodipin/Hct Ratiopharm is provided by GNH USA, a certified supplier adhering to global quality standards.

Olmesartan/Amlodipin/Hct Ratiopharm is indicated for hypertension management, acting on the renin‑angiotensin system and vascular smooth‑muscle tone. - Essential hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Hypertension with fluid retention: combines vasodilation with diuretic action to improve blood‑pressure control. - Hypertension in patients requiring multiple mechanisms: provides triple‑mechanism therapy (ARB, calcium‑channel blocker, thiazide diuretic).

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Headache - Peripheral edema - Dizziness - Flushing - Fatigue - Increased urination

Serious or Rare Side Effects: - Angio‑edema - Severe hypotension - Electrolyte disturbances (e.g., hyponatremia, hypokalemia) - Acute kidney injury - Liver enzyme elevation - Blood dyscrasias

When prescribing Olmesartan/Amlodipin/Hct Ratiopharm, clinicians should consider several safety aspects. - Renal function monitoring: assess baseline creatinine and eGFR, especially in patients with chronic kidney disease. - Electrolyte assessment: check serum potassium and sodium levels regularly. - Pregnancy contraindication: avoid use in pregnancy due to fetal toxicity. - Concomitant drug review: evaluate for other antihypertensives that may cause additive hypotension. - Patient education: advise on signs of low blood pressure and when to seek medical help. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Olmesartan/Amlodipin/Hct Ratiopharm may interact with several medicines; careful review is required.

Major Interactions (Avoid): - Dual renin‑angiotensin system blockade (e.g., ACE inhibitors, aliskiren) – increased risk of renal impairment and hyperkalaemia. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole) – may raise amlodipine levels.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs) – may blunt antihypertensive effect and affect renal function. - Lithium – increased lithium concentrations, risk of toxicity. - Digoxin – heightened risk of digoxin toxicity when combined with diuretics. - High‑dose potassium supplements – may exacerbate hyperkalaemia. - Alcohol – additive vasodilatory effect, may increase dizziness.